ArticleCurrent oncology (Toronto, Ont.)2015
A population-based study of ethnicity and breast cancer stage at diagnosis in Ontario.
Article in Current oncology (Toronto, Ont.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 30 citations in OpenAlex.
- The impact of translated reminder letters and phone calls on mammography screening booking rates: Two randomised controlled trials.PloS one · 2020Trial
- EXCEL-Punjabi: the process of using a community based participatory research approach for a culturally-tailored exercise oncology intervention.Research involvement and engagement · 2026Article
- COVID-19 impacts on the breast cancer care pathway among systemically marginalized communities in Ontario.Cancer causes & control : CCC · 2025Article
- Diversity and Experiences of Radiation Oncologists in Canada: A Survey of Gender Identity, Sexual Orientation, Disability, Race, Ethnicity, Religion, and Workplace Discrimination-A National Cross-Sectional Electronic Survey.Current oncology (Toronto, Ont.) · 2025Article
- CaSMO Recommendations for Prevention and Treatment of Cutaneous Adverse Events Related to Cancer Therapies in Darker Skin Phototypes.Clinical, cosmetic and investigational dermatology · 2025Article
- Integrating equity indicators for hospital reporting metrics.Research in health services & regions · 2024Article
- Predictive miRNAs Patterns in Blood of Breast Cancer Patients Demonstrating Resistance Towards Neoadjuvant Chemotherapy.Breast cancer (Dove Medical Press) · 2023Article
- Examination of Breast Cancer Screening Knowledge, Attitudes, and Beliefs among Syrian Refugee Women in a Western Canadian Province.The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres · 2022Article
- Treatment Modality and Trends in Survival for Gallbladder Cancer: a Population-Based Study.Journal of gastrointestinal cancer · 2021Article
- Change in treatment modality and trends in survival among stage I non-small cell lung cancer patients: a population-based study.Journal of thoracic disease · 2020Article
- Trends in survival based on treatment modality in patients with pancreatic cancer: a population-based study.Current oncology (Toronto, Ont.) · 2020Article
- Disparities in breast cancer diagnosis for immigrant women in Ontario and BC: results from the CanIMPACT study.BMC cancer · 2019Article
- Breast screening participation and retention among immigrants and nonimmigrants in British Columbia: A population-based study.Cancer medicine · 2018Article
- The global burden of women's cancers: a grand challenge in global health.Lancet (London, England) · 2017Review
- Patient-reported pain severity, pain interference and health status in HR+/HER2- advanced/metastatic breast cancer.ESMO open · 2017Article
- Heart disease and breast cancer perceptions: Ethnic differences and relationship to attentional bias.Health psychology open · 2016Article
- Ethnicity and breast cancer stage at diagnosis: an issue of health equity.Current oncology (Toronto, Ont.) · 2015Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast cancer stage at diagnosis is an important predictor of survival. Our goal was to compare breast cancer stage at diagnosis (by American Joint Committee on Cancer criteria) in Chinese and South Asian women with stage at diagnosis in the remaining general population in Ontario.
methodsWe used the Ontario population-based cancer registry to identify all women diagnosed with breast cancer during 2005-2010, and we applied a validated surname algorithm to identify South Asian and Chinese women. We used logistic regression to compare, for Chinese or South Asian women and for the remaining general population, the frequency of diagnoses at stage ii compared with stage i and stages ii-iv compared with stage i.
resultsThe registry search identified 1304 Chinese women, 705 South Asian women, and 39,287 women in the remaining general population. The Chinese and South Asian populations were younger than the remaining population (mean: 54, 57, and 61 years respectively). Adjusted for age, South Asian women were more often diagnosed with breast cancer at stage ii than at stage i [odds ratio (or): 1.28; 95% confidence interval (ci): 1.08 to 1.51] or at stages ii-iv than at stage i (or: 1.27; 95% ci: 1.08 to 1.48); Chinese women were less likely to be diagnosed at stage ii than at stage i (or: 0.82; 95% ci: 0.72 to 0.92) or at stages ii-iv than at stage i (or: 0.73; 95% ci: 0.65 to 0.82).
conclusionsBreast cancers were diagnosed at a later stage in South Asian women and at an earlier stage in Chinese women than in the remaining population. A more detailed analysis of ethnocultural factors influencing breast screening uptake, retention, and care-seeking behavior might be needed to help inform and evaluate tailored health promotion activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.